Tscharntke, Lene T. and Jung, Norma and Hanses, Frank and Koll, Carolin E. M. and Pilgram, Lisa and Rieg, Siegbert and Borgmann, Stefan and de Miranda, Susana M. Nunes and Scherer, Margarete and Spinner, Christoph D. and Ruethrich, Maria and Vehreschild, Maria J. G. T. and von Bergwelt-Baildon, Michael and Wille, Kai and Merle, Uta and Hower, Martin and Rothfuss, Katja and Nadalin, Silvio and Klinker, Hartwig and Fuerst, Julia and Greiffendorf, Ingo and Raichle, Claudia and Friedrichs, Anette and Rauschning, Dominic and de With, Katja and Eberwein, Lukas and Riedel, Christian and Milovanovic, Milena and Worm, Maximilian and Schultheis, Beate and Schubert, Joerg and Bota, Marc and Beutel, Gernot and Glueck, Thomas and Schmid, Michael and Wintermantel, Tobias and Peetz, Helga and Steiner, Stephan and Ribel, Elena and Schaefer, Harald and Vehreschild, Joerg Janne and Stecher, Melanie (2025) Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort. INFECTION, 53 (1). pp. 259-269. ISSN 0300-8126, 1439-0973
Full text not available from this repository. (Request a copy)Abstract
PurposeThis study investigates the care provision and the role of infectious disease (ID) specialists during the coronavirus disease-2019 (COVID-19) pandemic.MethodsA survey was conducted at German study sites participating in the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS). Hospitals certified by the German Society of Infectious diseases (DGI) were identified as ID centers. We compared care provision and the involvement of ID specialists between ID and non-ID hospitals. Then we applied a multivariable regression model to analyse how clinical ID care influenced the mortality of COVID-19 patients in the LEOSS cohort.ResultsOf the 40 participating hospitals in the study, 35% (14/40) were identified as ID centers. Among those, clinical ID care structures were more commonly established, and ID specialists were always involved in pandemic management and the care of COVID-19 patients. Overall, 68% (27/40) of the hospitals involved ID specialists in the crisis management team, 78% (31/40) in normal inpatient care, and 80% (28/35) in intensive care. Multivariable analysis revealed that COVID-19 patients in ID centers had a lower mortality risk compared to those in non-ID centers (odds ratio: 0.61 (95% CI 0.40-0.93), p = 0.021).ConclusionID specialists played a crucial role in pandemic management and inpatient care.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | MANAGEMENT; Infectious diseases medicine; COVID-19; Pandemic; Healthcare research; Healthcare quality; Quality indicators |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Abteilung für Krankenhaushygiene und Infektiologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 07 Apr 2026 12:13 |
| Last Modified: | 07 Apr 2026 12:13 |
| URI: | https://pred.uni-regensburg.de/id/eprint/65722 |
Actions (login required)
 |
View Item |
